Press Releases

Press Releases

    Date Title View
    05/24/21
    Summary ToggleHorizon Therapeutics plc to Participate in Upcoming Investor Conferences
    PDF Version
    05/21/21
    Summary ToggleHorizon Therapeutics plc Highlights Expanding R&D Efforts with Data Presentations at the EULAR European Congress of Rheumatology
    PDF Version
    05/20/21
    Summary ToggleHorizon Therapeutics plc Named One of the 2021 Best Workplaces in Chicago™ by Great Place to Work®
    PDF Version
    05/13/21
    Summary ToggleHorizon Therapeutics plc Ranked #1 in Overall Corporate Reputation Among U.S. Patient Groups that Report Working with the Company
    PDF Version
    05/06/21
    Summary ToggleHorizon Therapeutics plc to Present at the Bank of America Securities 2021 Health Care Conference
    PDF Version
    05/06/21
    Summary ToggleNew Analysis of UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD) Published in Neurology Neuroimmunology & Neuroinflammation
    PDF Version
    05/06/21
    Summary ToggleHorizon Therapeutics plc Announces Elizabeth H.Z. Thompson as a Healthcare Businesswomen’s Association 2021 Luminary
    PDF Version
    05/05/21
    Summary ToggleHorizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.
    04/27/21
    Summary ToggleHorizon Therapeutics plc Ranks Among the Top Companies in Overall Corporate Reputation in 2020 PatientView Survey of Patient Organizations Worldwide
    PDF Version
    04/16/21
    Summary ToggleNew Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
    PDF Version
    Displaying 11 - 20 of 590 results